x min read

Eye Catching Stocks: BlackBerry Ltd (NASDAQ:BBRY), Akorn, Inc. (NASDAQ:AKRX), Curis, Inc. (NASDAQ:CRIS), Reis, Inc. (NASDAQ:REIS), Lockheed Martin Corporation (NYSE:LMT)

Eye Catching Stocks: BlackBerry Ltd (NASDAQ:BBRY), Akorn, Inc. (NASDAQ:AKRX), Curis, Inc. (NASDAQ:CRIS), Reis, Inc. (NASDAQ:REIS), Lockheed Martin Corporation (NYSE:LMT)
Written by
Charles Donlon
Published on
November 7, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

BlackBerry Ltd (NASDAQ:BBRY) has started sending out email notifications to enterprise customers informing them that BES12 is very much on its way. The next generation of BlackBerry Enterprise Server (BES) is expected to launch on November 13th. BlackBerry Ltd (NASDAQ:BBRY) belongs to Technology sector. Its net profit margin is -6.73% and weekly performance is -2.00%. On last trading day company shares ended up $10.27. BlackBerry Ltd (NASDAQ:BBRY) distance from 50-day simple moving average (SMA50) is 1.24%. Akorn, Inc. (NASDAQ:AKRX) reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The company had revenue of $132.70 million for the quarter, compared to the consensus estimate of $155.20 million. During the same quarter in the previous year, the company posted $0.15 earnings per share. The company’s revenue for the quarter was up 110.8% on a year-over-year basis. Akorn, Inc. (NASDAQ:AKRX) shares moved down -9.12% in last trading session and ended the day at $37.88. AKRX Gross Margin is 53.20% and its return on assets is 7.50%. Akorn, Inc. (NASDAQ:AKRX) quarterly performance is 10.37%. Curis Inc. (NASDAQ:CRIS), an oncology-focused biotechnology company developing novel drug candidates for the treatment of human cancers, announced in a press release the receipt of a Notice of Allowance of a US patent that covers a broad genus of compounds that target histone deacetylase (HDAC) and phosphoinositide 3-kinase (PI3K) activities in a single chemical structure including CUDC-907, Curis' oral, dual HDAC and PI3K small molecule inhibitor that is currently being studied in Phase 1 clinical trials. On 06 November, Curis, Inc. (NASDAQ:CRIS) shares increased 1.57% and was closed at $1.29. CRIS EPS growth in last 5 year was 4.60%. Curis, Inc. (NASDAQ:CRIS) year to date (YTD) performance is -54.26%. New York-based Reis Inc. (NASDAQ:REIS), a real estate research firm, reported third quarter apartment vacancy in Minneapolis-St. Paul at 3.2 percent for the third quarter, lower than the national vacancy rate of 4.2 percent. (Different reports will often report different numbers due to variations in methodology.) Reis, Inc. (NASDAQ:REIS) ended the last trading day at $25.24. Company weekly volatility is calculated as 4.08% and price to cash ratio as 17.14. Reis, Inc. (NASDAQ:REIS) showed a weekly performance of 8.89%. Lockheed Martin [NYSE: LMT] has partnered with the University of Arizona to operate the United Kingdom Infrared Telescope (UKIRT) located on Maunakea, Hawaii. The agreement expands the corporation's support of scientists pursuing a broad range of research, from the study of orbital debris to deep space astronomy. Lockheed Martin Corporation (NYSE:LMT) shares increased 0.08% in last trading session and ended the day at $189.88. LMT Gross Margin is 11.40% and its return on assets is 8.70%. Lockheed Martin Corporation (NYSE:LMT) quarterly performance is 15.39%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You